Prognostic properties of the baseline prostate-specific antigen value-insights from the European randomized study of screening for prostate cancer

被引：0
|
作者：
Scherer, Thomas Paul [1 ]
Poyet, Cedric [1 ,2 ]
机构：
[1] Univ Zurich, Univ Hosp Zurich, Dept Urol, Zurich, Switzerland
[2] Univ Hosp Zurich, Dept Urol, Ramistr 100, CH-8091 Zurich, Switzerland
来源：
TRANSLATIONAL ANDROLOGY AND UROLOGY | 2024年 / 13卷 / 03期
关键词：
Screening; prostate-specific antigen (PSA); prostate cancer (PCa); RISK;
D O I：
10.21037/tau-23-606
中图分类号：
R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
摘要：
引用
收藏
页码：473 / 475
页数：3
相关论文
共 50 条
  • [41] Prostate-specific antigen-based prostate cancer screening: Past and future
    Alberts, Arnout R.
    Schoots, Ivo G.
    Roobol, Monique J.
    INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (06) : 524 - 532
  • [42] Screening for Prostate Cancer With the Prostate-Specific Antigen Test A Review of Current Evidence
    Hayes, Julia H.
    Barry, Michael J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (11): : 1143 - 1149
  • [43] The Utility of Prostate-Specific Antigen Screening and Prostate Cancer Treatment in Elderly Patients
    Annelies Vellekoop
    Stacy Loeb
    Current Translational Geriatrics and Experimental Gerontology Reports, 2013, 2 (2): : 51 - 57
  • [44] The value of prostate-specific antigen in Asia
    Mochtar, Chaidir Arif
    Andika, R. Siddhi
    THERAPEUTIC ADVANCES IN UROLOGY, 2010, 2 (02) : 77 - 83
  • [45] The relationship between diabetes, prostate-specific antigen screening tests, and prostate cancer
    Miller, Eric A.
    Pinsky, Paul F.
    Pierre-Victor, Dudith
    CANCER CAUSES & CONTROL, 2018, 29 (10) : 907 - 914
  • [46] The Impact of Interscreening Interval and Age on Prostate Cancer Screening With Prostate-Specific Antigen
    Wu, Grace Hui-Min
    Auvinen, Anssi
    Yen, Amy Ming-Fang
    Hakama, Matti
    Tammela, Teuvo L.
    Stenman, Ulf-Hakan
    Kujala, Paula
    Ruutu, Mirja
    Chen, Hsiu-Hsi
    EUROPEAN UROLOGY, 2012, 61 (05) : 1011 - 1018
  • [47] Effect of body mass index on prostate-specific antigen and percentage free prostate-specific antigen: Results from a prostate cancer screening cohort of 1490 men
    Capitanio, Umberto
    Perrotte, Paul
    Hutterer, Georg C.
    Suardi, Nazareno
    Jeldres, Claudio
    Shariat, Shahrokh F.
    Duclos, Alain
    Arjane, Philippe
    Montorsi, Francesco
    Karakiewicz, Pierre I.
    INTERNATIONAL JOURNAL OF UROLOGY, 2009, 16 (01) : 91 - 95
  • [48] Prostate-specific antigen-based screening for prostate cancer: Evidence, controversies and future perspectives
    Ito, Kazuto
    INTERNATIONAL JOURNAL OF UROLOGY, 2009, 16 (05) : 458 - 464
  • [49] Prostate-specific antigen screening for prostate cancer: Diagnostic performance, clinical thresholds, and strategies for refinement
    Sundaresan, Vinaik M.
    Smani, Shayan
    Rajwa, Pawel
    Renzulli, Joseph
    Sprenkle, Preston C.
    Kim, Isaac Y.
    Leapman, Michael S.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (01) : 41 - 48
  • [50] Prostate-Specific Membrane Antigen Expression in Patients with Primary Prostate Cancer: Diagnostic and Prognostic Value in Positron Emission Tomography-Prostate-Specific Membrane Antigen
    Tayara, Omar
    Poletajew, Slawomir
    Malewski, Wojciech
    Kunikowska, Jolanta
    Pelka, Kacper
    Kryst, Piotr
    Nyk, Lukasz
    CURRENT ONCOLOGY, 2024, 31 (08) : 4165 - 4177
12345